1434
M.-K. Jeon et al.
LETTER
(5) For examples, see: (a) Laschober, R.; Stadlbauer, W.
and purities of the crude and purified products 9 are
summarized in Table 1.17 The compounds 9 are unknown
except 9b,18a 9f,18b 9i,18c 9l,18d and 9m,9a and all final
Liebigs Ann. Chem. 1990, 1083. (b) Lange, J. H. M.;
Verveer, P. C.; Osnabrug, S. J. M.; Visser, G. M.
Tetrahedron Lett. 2001, 42, 1367. (c) Xiao, Z.; Waters, N.
C.; Woodard, C. L.; Li, Z.; Li, P.-K. Bioorg. Med. Chem.
Lett. 2001, 11, 2875.
1
products 9a–y were characterized on the basis of H
NMR, (13C NMR) and LC-UV-MS spectral data.
(6) For examples, see: (a) Ukrainets, I. V.; Taran, S. G.;
Gorokhova, O. V.; Kodolova, O. L.; Turov, A. V. Khim.
Geterotsikl. Soedin 1997, 33, 928. (b) Kulkarni, B. A.;
Ganesan, A. Chem. Commun. 1998, 785. (c) DeVita, R. J.;
Goulet, M. T.; Wyvratt, M. J.; Fisher, M. H.; Lo, J.-L.; Yang,
Y. T.; Cheng, K.; Smith, R. G. Bioorg. Med. Chem. Lett.
1999, 9, 2621. (d) Walsh, T. F.; Toupence, R. B.; Young, J.
R.; Huang, S. X.; Ujjainwalla, F.; DeVita, R. J.; Goulet, M.
T.; Wyvratt, M. J. Jr.; Fisher, M. H.; Lo, J.-L.; Ren, N.;
Yudkovitz, J. B.; Yang, Y. T.; Cheng, K.; Smith, R. G.
Bioorg. Med. Chem. Lett. 2000, 10, 443. (e) Spears, G. W.;
Tsuji, K.; Tojo, T.; Nishimura, H.; Ogino, T. J. Heterocycl.
Chem. 2002, 39, 799.
(7) For examples, see: (a) Ismaili, L.; Refouvelet, B.; Robert, J.
F. J. Heterocycl. Chem. 1999, 36, 719. (b) Tojo, T.; Spears,
G. W.; Tsuji, K.; Nishimura, H.; Ogino, T.; Seki, N.;
Sugiyama, A.; Matsuo, M. Bioorg. Med. Chem. Lett. 2002,
12, 2427. (c) Mitsos, C. A.; Zografos, A. L.; Igglessi-
Markopoulou, O. J. Org. Chem. 2003, 68, 4567.
In brief, we were able to establish a novel solid-phase
synthetic method for 4-hydroxyquinolin-2(1H)-one
derivatives 9 utilizing polymer-bound anthranilic acid
derivatives 1, securing sufficient functional group com-
patibility at 3-position of the skeleton, and introducing
alkyl substituents at its 1-position on solid phase, suitable
for library generation without amendment or with some
modifications. The reactions on solid phase were checked
by single-bead ATR-FTIR spectroscopic methods, colori-
metric tests, and/or cleavage experiments. Now we are
pursuing modified forms of the protocol, useful for con-
struction of target-directed 4-hydroxyquinolin-2(1H)-
one-based libraries. In addition, the investigation into ef-
ficient methods for other heterocyclic compounds utiliz-
ing the resin-bound anthranilic acid derivatives 1 and 2 is
in progress.
(8) (a) Borowiec, H.; Grochowski, J.; Serda, P. J. Chem. Res.,
Synop. 1996, 248. (b) El Kihel, A.; Benchidmi, M.; Essassi,
E. M.; Bauchat, P.; Danion-Bougot, R. Synth. Commun.
1999, 29, 2435. (c) Jung, J.-C.; Jung, Y.-J.; Park, O.-S.
Synth. Commun. 2001, 31, 1195. (d) Jung, J.-C.;Jung, Y.-J.;
Park, O.-S. J. Heterocycl. Chem. 2001, 38, 61.
(9) (a) Sim, M. M.; Lee, C. L.; Ganesan, A. Tetrahedron Lett.
1998, 39, 6399. (b) Xu, C.; Yang, L.; Bhandari, A.; Holmes,
C. P. Tetrahedron Lett. 2006, 47, 4885: The recent report
described the solid-phase synthesis of 3-carbomethoxy-4-
hydoxyquinolin-2(1H)-one bound to a resin through the
bonding to nitrogen at 1-position as an intermediate resin for
introduction of carbon-based substituents at 4-position of
quinolin-2(1H)-one skeleton.
Acknowledgment
We are grateful to Seoul Research and Business Development Pro-
gram (grant number 10574), the Center for Biological Modulators,
and Korea Research Institute of Chemical Technology for financial
support of this research.
References and Notes
(1) Dolle, R. E.; Le Bourdonnec, B.; Morales, G. A.; Moriarty,
K. J.; Salvino, J. M. J. Comb. Chem. 2006, 8, 597.
(2) (a) Gordon, E. M.; Gallop, M. A.; Patel, D. V. Acc. Chem.
Res. 1996, 29, 144. (b) Tempest, P. A.; Armstrong, R. W.
J. Am. Chem. Soc. 1997, 119, 7607. (c) Ding, S.; Gray, N.
S.; Wu, X.; Ding, Q.; Schultz, P. G. J. Am. Chem. Soc. 2002,
124, 1594. (d) Burke, M. D.; Schreiber, S. L. Angew. Chem.
Int. Ed. 2004, 43, 46. (e) Marzinzik, A. L.; Felder, E. R.
J. Org. Chem. 1998, 63, 723.
(3) (a) Jeon, M.-K.; Kim, D.-S.; La, H. J.; Ha, D.-C.; Gong, Y.-
D. Tetrahedron Lett. 2005, 46, 7477. (b) Jeon, M.-K.; Kim,
D.-S.; La, H. J.; Gong, Y.-D. Tetrahedron Lett. 2005, 46,
4979.
(4) (a) Rowley, M.; Kulagowski, J. J.; Watt, A. P.; Rathbone,
D.; Stevenson, G. I.; Carling, R. W.; Baker, R.; Marshall, G.
R.; Kemp, J. A.; Foster, A. C.; Grimwood, S.; Hargreaves,
R.; Hurley, C.; Saywell, K. L.; Tricklebank, M. D.; Leeson,
P. D. J. Med. Chem. 1997, 40, 4053. (b)Hayashi, H.; Miwa,
Y.; Ichikawa, S.; Yoda, N.; Miki, I.; Ishii, A.; Kono, M.;
Yasuzawa, T.; Suzuki, F. J. Med. Chem. 1993, 36, 617.
(c) DeVita, R. J.; Walsh, T. F.; Young, J. R.; Jiang, J.;
Ujjainwalla, F.; Toupence, R. B.; Parikh, M.; Huang, S. X.;
Fair, J. A.; Goulet, M. T.; Wyvratt, M. J.; Lo, J.-L.; Ren, N.;
Yudkovitz, J. B.; Yang, Y. T.; Cheng, K.; Cui, J.; Mount, G.;
Rohrer, S. P.; Schaeffer, J. M.; Rhodes, L.; Drisko, J. E.;
McGowan, E.; MacIntyre, D. E.; Vincent, S.; Carlin, J. R.;
Cameron, J.; Smith, R. G. J. Med. Chem. 2001, 44, 917.
(d) Khan, S. R.; Mhaka, A.; Pili, R.; Isaacs, J. T. Bioorg.
Med. Chem. Lett. 2001, 11, 451. (e) Tsuji, K.; Spears, G.
W.; Nakamura, K.; Tojo, T.; Seki, N.; Sugiyama, A.;
Matsuo, M. Bioorg. Med. Chem. Lett. 2002, 12, 85.
(10) In addition to commercially available 2-nitrobenzoic acids,
they can be prepared from the regioselective nitration of
benzoic acids, the oxidation of o-nitrotoluenes, 2-
nitrobenzyl alcohols, 2-nitrobenzaldehydes, and 2¢-
nitroacetophenones, and the substitutions of halogenated 2-
nitrobenzoic acids. On the other hand, variation of the X
group would be possible for the resin-bound 2-nitrobenzoic
acid derivatives 6 and will be reported elsewhere. For
examples of the nitration, see ref. 8d and: (a) Coppola, G.
M.; Schuster, H. F. J. Heterocycl. Chem. 1989, 26, 957.
(b) Cotelle, P.; Catteau, J. P. Synth. Commun. 1996, 26,
4105. (c) Thurston, D. E.; Bose, D. S.; Thompson, A. S.;
Howard, P. W.; Leoni, A.; Croker, S. J.; Jenkins, T. C.;
Neidle, S.; Hartley, J. A.; Hurley, L. H. J. Org. Chem. 1996,
61, 8141. (d) Gregson, S. J.; Howard, P. W.; Thurston, D. E.
Bioorg. Med. Chem. Lett. 2003, 13, 2277. For examples of
the oxidation, see: (e) Yamazaki, S. Synth. Commun. 1999,
29, 2211. (f) Sawatari, N.; Sakaguchi, S.; Ishii, Y.
Tetrahedron Lett. 2003, 44, 2053. (g) Venturello, C.;
Cambaro, M. J. Org. Chem. 1991, 56, 5924. (h) Singh, M.;
Singh, K. N.; Dwivedi, S.; Misra, R. A. Synthesis 1991, 291.
(i) Das, S.; Punniyamurthy, T. Tetrahedron Lett. 2003, 44,
6033. (j) De Luca, L.; Giacomelli, G.; Masala, S.;
Porcheddu, A. J. Org. Chem. 2003, 68, 4999. (k) Madler,
M. M.; Klucik, J.; Soell, P. S.; Brown, C. W.; Liu, S.; Berlin,
K. D.; Benbrook, D. M.; Birckbichler, P. J.; Nelson, E. C.
Org. Prep. Proced. Int. 1998, 30, 230. (l) Roy, A.; Reddy,
K. R.; Mohanta, P. K.; Ila, H.; Junjappa, H. Synth. Commun.
Synlett 2007, No. 9, 1431–1435 © Thieme Stuttgart · New York